Skip to main content

The Children's Vaccine Initiative Continuing Activities (1995) / Chapter Skim
Currently Skimming:

FACILITATING GREATER U.S. INVOLVEMENT
Pages 35-38

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 35...
... Although donor agencies can create market demand by buying vaccine for a particular region, this approach can lead to dependency unless the recipient country is able to begin purchasing vaccine with its own resources. Manufacturers at the workshop indicated they saw no distinction between the public and private sectors in the developing world and would oppose such "segmentation" if it restricted their access to potential markets.
Read the entire page →
From page 36...
... citizens should not pay more than those in other countries for medicinals including vaccines made in the United States. With the exception of limited sales to individual countries, U.S firms have not sold vaccine at reduced prices outside the United States since the early 1980s, when questions about the practice arose in congressional hearings.
Read the entire page →
From page 37...
... Technology transfer frequently involves partnerships between the public and private sectors and these collaborations can cut across the boundaries of developed and developing nations. For example, with support from the public sector, U.S.
Read the entire page →
From page 38...
... Therefore, another key component of technology transfer is ongoing training. Workshop participants also discussed a concept paper that presented a comprehensive approach to technology transfer.
Read the entire page →

Key Terms

  • workshop participant
  • tiered pricing
  • developing nations
  • vaccine industry
  • potential markets

  • vaccine makers
  • manufacturing experience
  • public sector
  • ongoing training
  • prices outside

  • orphan vaccines
  • run counter
  • advanced vaccine
  • manufacturing practices
  • native english

  • manufacturing equipment
  • european vaccine
  • create products
  • participants discussed
  • additional tests

  • vaccine manufacturing
  • participant noted
  • resulting increase
  • agency involved
  • production technology

  • individual countries
  • frequently involves
  • expensive steps
  • health dollars
  • company wishing


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.